Geoffrey von Maltzahn, Tessera CEO

With a tor­rent of ven­ture cash gush­ing from a glob­al pack of uni­corn hunters, this biotech founder vows to stay hun­gry

What­ev­er fac­tors may be lim­it­ing the am­bi­tions of Tessera, ready cash isn’t one of them.

The start­up that de­buted in a pan­dem­ic, in­spired by a new ap­proach to gene edit­ing — per­haps the hottest of all siz­zling new biotech trends — and fo­cused on build­ing the next big plat­form play, has or­ga­nized a uni­corn-hunt­ing glob­al syn­di­cate of back­ers to fund a hir­ing spree as they set a course to the clin­ic.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.